Collins Helen Louise
CHIEF MEDICAL OFFICER at ELVN
- Sold, on record
- $6.1M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Nov 17, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ELVNEnliven Therapeutics, Inc.CHIEF MEDICAL OFFICER
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ELVNRoutineMar 25, 2026 2026
Sold 40,000 shares at $35.10 ($1.4M)
Collins Helen Louise, CHIEF MEDICAL OFFICER
10b5-1 planSold 61.5% of holdings ($2.3M position)25,000 shares left2x usual sizeFiling
- 2 Form 4 sale ELVNRoutineApr 17, 2026 +23 days
Sold 5,000 shares at $47.67 ($238k)
Collins Helen Louise, CHIEF MEDICAL OFFICER
10b5-1 planSold 16.7% of holdings ($1.4M position)25,000 shares left0.1x usual sizeFiling
- 3 Form 4 sale ELVNRoutineMay 18, 2026 +31 days
Sold 5,000 shares at $39.79 ($199k)
Collins Helen Louise, CHIEF MEDICAL OFFICER
10b5-1 planSold 16.7% of holdings ($1.2M position)25,000 shares left0.2x usual sizeFiling
- 4 Form 4 sale ELVNRoutineJun 17, 2026 +30 days
Sold 5,000 shares at $43.80 ($219k)
Collins Helen Louise, CHIEF MEDICAL OFFICER
10b5-1 planSold 16.7% of holdings ($1.3M position)25,000 shares left1x usual sizeFiling
- 5 Form 4 sale ELVNRoutineJul 17, 2026 +30 days
Sold 5,000 shares at $52.67 ($263k)
Collins Helen Louise, CHIEF MEDICAL OFFICER
10b5-1 planSold 16.7% of holdings ($1.6M position)25,000 shares left1x usual sizeFiling
- 6 Form 4 sale ELVNRoutineAug 17, 2026 +31 days
Sold 5,000 shares at $58.59 ($293k)
Collins Helen Louise, CHIEF MEDICAL OFFICER
10b5-1 planSold 16.7% of holdings ($1.8M position)25,000 shares left1x usual sizeFiling
- 7 Form 4 sale ELVNRoutineSep 17, 2026 +31 days
Sold 5,000 shares at $50.35 ($252k)
Collins Helen Louise, CHIEF MEDICAL OFFICER
10b5-1 planSold 16.7% of holdings ($1.5M position)25,000 shares left1x usual sizeFiling
- 8 Form 4 sale ELVNRoutineNov 17, 2026 +61 days
Sold 5,000 shares at $46.84 ($234k)
Collins Helen Louise, CHIEF MEDICAL OFFICER
10b5-1 planSold 16.7% of holdings ($1.4M position)25,000 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (15)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | Nov 19, 2026 | ELVN | CHIEF MEDICAL OFFICER | Form 4 sale | 5,000 | $234k | 16.7% | Routine | SEC |
| Sep 17, 2026 | Sep 21, 2026 | ELVN | CHIEF MEDICAL OFFICER | Form 4 sale | 5,000 | $252k | 16.7% | Routine | SEC |
| Aug 17, 2026 | Aug 19, 2026 | ELVN | CHIEF MEDICAL OFFICER | Form 4 sale | 5,000 | $293k | 16.7% | Routine | SEC |
| Jul 17, 2026 | Jul 21, 2026 | ELVN | CHIEF MEDICAL OFFICER | Form 4 sale | 5,000 | $263k | 16.7% | Routine | SEC |
| Jun 17, 2026 | Jun 22, 2026 | ELVN | CHIEF MEDICAL OFFICER | Form 4 sale | 5,000 | $219k | 16.7% | Routine | SEC |
| May 18, 2026 | May 20, 2026 | ELVN | CHIEF MEDICAL OFFICER | Form 4 sale | 5,000 | $199k | 16.7% | Routine | SEC |
| Apr 17, 2026 | Apr 21, 2026 | ELVN | CHIEF MEDICAL OFFICER | Form 4 sale | 5,000 | $238k | 16.7% | Routine | SEC |
| Mar 25, 2026 | Mar 27, 2026 | ELVN | CHIEF MEDICAL OFFICER | Form 4 sale | 40,000 | $1.4M | 61.5% | Routine | SEC |
| Mar 17, 2026 | Mar 19, 2026 | ELVN | CHIEF MEDICAL OFFICER | Form 4 sale | 5,000 | $139k | 16.7% | Routine | SEC |
| Mar 10, 2026 | Mar 11, 2026 | ELVN | CHIEF MEDICAL OFFICER | Form 4 sale | 40,000 | $1.2M | 61.5% | Routine | SEC |
| Feb 17, 2026 | Feb 19, 2026 | ELVN | CHIEF MEDICAL OFFICER | Form 4 sale | 45,000 | $1.2M | 64.3% | Routine | SEC |
| Oct 18, 2024 | Oct 22, 2024 | ELVN | CHIEF MEDICAL OFFICER | Form 4 sale | 816 | $24k | 100.0% | Routine | SEC |
| Oct 18, 2024 | Oct 18, 2024 | ELVN | Officer | Form 144 notice | 25,000 | $701k | Notice | SEC | |
| Apr 11, 2024 | Apr 15, 2024 | ELVN | CHIEF MEDICAL OFFICER | Form 4 sale | 20,000 | $501k | 100.0% | Routine | SEC |
| Apr 11, 2024 | Apr 11, 2024 | ELVN | Officer | Form 144 notice | 20,000 | $396k | Notice | SEC |